ALLOSTERIC, SMALL-MOLECULE LIGANDS OF PAR1 FOR THE TREATMENT OF DIABETIC NEPHROPATHY

$285,133FY2022Defense Health AgencyDOD

Function Therapeutics Llc

Investigators

View source on USAspending →